Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (32)
  • 2025 (118)
  • 2024 (135)
  • 2023 (151)
  • 2022 (211)
  • 2021 (125)
  • 2020 (14)
  • 2019 (7)

Subject

  • Drug Trafficking (4210)
  • Synthetic drugs (1141)
  • Guns/Weapons (1041)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (646)
  • Seizures (Drugs/Property) (484)
  • Prescription Drugs (372)
  • Overdose (327)
  • Major Law Enforcement Operation (278)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (239)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (189)
  • Fentanyl Awareness (167)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (69)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (41)
  • Counterfeit Pills (39)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Campaigns (14)
  • Terrorism (14)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Guilty Plea (559)
  • Diversion Division (254)

Drug Name

  • Methamphetamine (231)
  • Fentanyl (200)
  • Cocaine (136)
  • Heroin (81)
  • Opioids (45)
  • Oxycodone (43)
  • Marijuana (Cannabis) (26)
  • Hydromorphone (16)
  • Synthetic Opioids (16)
  • Benzodiazepines (10)
  • Morphine (9)
  • Ketamine (5)
  • Steroids (5)
  • Amphetamines (4)
  • Ecstasy/MDMA (4)
  • Methadone (4)
  • Marijuana Concentrates (2)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Chicago (182)
  • Miami (93)
  • Seattle (64)
  • Washington, DC (60)
  • St. Louis (48)
  • New Jersey (47)
  • New England (44)
  • Atlanta (39)
  • Houston (38)
  • New York (35)
  • El Paso (29)
  • San Francisco (27)
  • Dallas (16)
  • San Diego (10)
  • Sede (10)
  • New Orleans (9)
  • Phoenix (9)
  • Detroit (7)
  • Omaha (7)
  • Rocky Mountain (7)
  • Los Angeles (6)
  • Louisville (5)
Clear All Results
793 Results - Showing 771 to 780
PRESS RELEASE

Man from Albuquerque pleads guilty to federal armed robbery of medical products and drug charges

ALBUQUERQUE, N.M. – Joseph Matney, 40, of Albuquerque, New Mexico, pleaded guilty in federal court on Feb. 4 to armed robbery of a pharmacy, theft of medical products and possession with intent to distribute Oxycodone and Alprazolam. According to his plea agreement, Matney entered and robbed an Albuquerque pharmacy on...
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
PRESS RELEASE

Troy man admits to trafficking 10 kilograms of heroin

ALBANY, N.Y. - Mario Figueroa-Portalatin, age 41, of Troy, New York, pled guilty today to conspiring to distribute 10 kilograms of heroin. The announcement was made by United States Attorney Grant C. Jaquith; Special Agent in Charge Ray Donovan, U.S. Drug Enforcement Administration (DEA), New York Division; and Rensselaer County...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

Former Long Island Doctor Pleads Guilty to conspiring to illegally distribute oxycodone

BROOKLYN, N.Y. - Earlier today, in federal court in Central Islip, Tameshwar Ammar, a former medical doctor in Roslyn, New York, pleaded guilty via teleconference to conspiring to illegally distribute oxycodone. Ammar was indicted in November 2019. On June 22, 2020, he relinquished his license to practice medicine. Today’s plea...
PRESS RELEASE

Syracuse man sentenced to nearly eight years in prison in RICO gang case

SYRACUSE, N.Y. –Wynn, 43, of Syracuse, New York, was sentenced today to serve 92 months in prison for violating the Racketeering Influenced Corrupt Organizations Act (RICO) as part of the 110 Gang. In imposing sentence, Senior United States District Judge Frederick J. Scullin, Jr. also ordered Wynn to serve three...
PRESS RELEASE

Doctor Pleads Guilty In Manhattan Federal Court To Illegal Distribution of Oxycodone From Brooklyn Clinic

NEW YORK - Today, Ray Donovan, Special Agent in Charge of the New York Field Division of the Drug Enforcement Administration (“DEA”), Audrey Strauss, the Acting United States Attorney for the Southern District of New York, Leigh-Alistair Barzey, Special Agent in Charge of the Northeast Field Office of the U.S...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

Paginación

  • Primera página «
  • Anterior
  • Page 72
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Current page 78
  • Page 79
  • Page 80
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster